Immediate Impact
67 standout
Citing Papers
Invasion and metastasis in cancer: molecular insights and therapeutic targets
2025 Standout
Antioxidants: a comprehensive review
2025 Standout
Works of Erik Škof being referenced
Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment
2022
Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Erik Škof | 164 | 105 | 43 | 70 | 31 | 320 | |
| Luis Z. Blanco | 160 | 86 | 36 | 32 | 31 | 341 | |
| Solange Moraes Sanches | 169 | 68 | 29 | 75 | 33 | 338 | |
| Angela Chan | 190 | 57 | 35 | 46 | 26 | 339 | |
| Fiona Nussey | 170 | 186 | 74 | 47 | 21 | 365 | |
| G. Rangoni | 110 | 140 | 14 | 66 | 26 | 350 | |
| Jennifer McLachlan | 112 | 115 | 23 | 58 | 20 | 271 | |
| F. Khomsi | 74 | 46 | 46 | 78 | 30 | 281 | |
| Mary M. Mullen | 131 | 63 | 14 | 57 | 28 | 261 | |
| Alisia Cesta | 189 | 98 | 21 | 52 | 20 | 330 | |
| Maciej Stukan | 85 | 146 | 99 | 94 | 42 | 361 |
All Works
Login with ORCID to disown or claim papers
Loading papers...